clinical trial · NCT07538544
MCE Molecular Imaging for ICI Myocarditis
Immune Checkpoint Inhibitor MyocarditisMyocardial contrast echocardiography molecular imaging for inflammation
brief summary
Inflammation of the heart (myocarditis) is a serious condition that can cause heart failure, abnormal heart rhythms, cardiac arrest, and death. A new class of medications used for cancer called immune checkpoint inhibitors (ICI) work by increasing the body's inflammmation response, but can have a side effect of causing inflammation of the heart (ICI myocarditis). Rapid diagnosis of this condition is key to reversing it. The purpose of this study is to determine whether ICI myocarditis can be diagnosed using a new form of ultrasound imaging of the heart (echocardiography) that uses a contrast agent that is targeted to inflammation (Sonazoid).
started
Jul 1, 2026
primary completion
Jun 30, 2030
completion
Jul 1, 2030
last updated
Apr 20, 2026
official title
MCE Molecular Imaging in ICI Myocarditis
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol